|Venture Round, 12/2011 |
Access BridgeGap Ventures
Novel Therapeutic Technology Inc. (NTT) is a leading pioneer in the development of sophisticated and practical drug delivery systems. NTT’s Ethosome technology provides the means to significantly enhance drug penetration of topical delivery applications, exponentially increasing therapeutic efficiency. With worldwide recognized drugs combined with NTT know-how, Pharmaceutical companies are able to introduce new and better drugs to the market, thus greatly reducing side effects, improving patient compliance, and increasing the patient’s quality of life.